Ascendis Pharma A/S ASND
NASDAQ · United States · Health Technology
$228.25+0.42 (+0.18%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | 3.23 | 1.71 | +89.1% | $387.48M | +2.8% | -2.7%$255.46→$248.50 |
| Q1 2026 | 2026-05-07 | 0.32 | 0.21 | +52.4% | — | — | +1.2%$235.90→$238.66 |
| Q4 2025 | 2026-02-11 | -0.55 | -0.24 | -129.2% | — | — | -2.7%$224.19→$218.10 |
| Q3 2025 | 2025-11-12 | -1.00 | -0.12 | -733.3% | — | — | +2.6%$201.16→$206.45 |
| Q4 2024 | 2025-02-12 | -0.64 | -1.17 | +45.3% | — | — | — |
| Q3 2024 | 2024-11-14 | -1.72 | -1.46 | -17.8% | — | — | — |
| Q2 2024 | 2024-09-03 | -1.91 | -1.34 | -42.5% | — | — | — |
| Q4 2023 | 2024-02-07 | -1.54 | -1.76 | +12.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.